Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine for Obesity Stratified by FTO Genotype
NCT03525002Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- May 2018
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bromocriptine in obesity, sponsored by University Hospital Tübingen. Started May 2018; status: completed.
02
Drugs
bromocriptine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03525002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03525002.